Definitive Contract HHSD200200828115C
Award Date
9/10/08
Potential Completion Date
5/9/12
Potential Value
$2M
Federal Agency
CDC Pittsburgh
Awardee
Marshfield Clinic, Inc.
Ultimate Awardee
Marshfield Clinic Health System, Inc.
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
AN81 - R&D- Medical: Aids Research (Basic Research)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Marshfield, WI, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc. for a follow-up study to assess immunogenicity associated with a third dose of the measles-mumps-rubella (MMR) vaccine. The contract has a total potential value of $99,565.00 and a completion date of July 31, 2019. Marshfield Clinic is the only source with access to the cohort of 665 subjects who are clients of the clinic, and the contract is sole-sourced under the...
This is a firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization. The contract, titled "MMR3 LONG TERM FOLLOW UP STUDY", has a ceiling value of $280,051 and an ultimate completion date of June 4, 2022. The contract does not have a set-aside designation. Marshfield Clinic, Inc. is the prime contractor, and there are no subcontractors mentioned. This contract is part of the Vaccine...
Marshfield Clinic, Inc. was awarded a $200,030 firm fixed price purchase order by the Centers for Disease Control and Prevention to conduct a follow-up measles, mumps, and rubella vaccine response study. The award was made without a set-aside designation under a June 2020 solicitation seeking a contractor to perform targeted DNA sequencing of samples from participants in the Centers for Disease Control and Prevention's MMR3 Long-Term Follow-Up Study. Marshfield Clinic will sequence genomic...
This federal contract award, with ID HHSD200201457941C, was issued by the Centers for Disease Control and Prevention (CDC) to the prime contractor Marshfield Clinic, Inc., a non-profit healthcare organization. The $435,047.82 definitive cost-no-fee contract is for vaccine safety data link services, linking databases from managed care organizations and health plans to enable the CDC to study vaccine safety issues and conduct rapid analyses. This contract is part of the Vaccine Safety Datalink...
This is a firm fixed price delivery order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (HHS CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization, for the Vaccine Safety Datalink Project Annual Conference. The $83,195 contract has a completion date of June 30, 2023 and is not set aside. Marshfield Clinic, Inc. is operating under the Vaccine Safety Datalink Project master contract, an indefinite-delivery task order with a...
This is a $3,760,872.70 delivery order awarded to Marshfield Clinic, Inc. by the Centers for Disease Control and Prevention (CDC) under the Vaccine Safety Datalink (VSD) master contract. The VSD is an indefinite-delivery/indefinite-quantity (IDIQ) multiple award contract with a potential value of $149 million, which enables the CDC to study vaccine safety issues and conduct rapid analyses. Under this task order, Marshfield Clinic will provide linked data, scientific expertise, and technical...
This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization, to support the Vaccine Safety Datalink Project. The $106,695 firm fixed-price delivery order is for critical functions related to this project, which involves vaccine safety research, data collection and analysis, and linked database capabilities to enable the CDC's vaccine safety analyses. Marshfield Clinic...
The Centers for Disease Control and Prevention (CDC) awarded a $658,016 definitive contract to Marshfield Clinic, Inc. for "OPTIMAL STRATEGIES TO ESTIMATE THE RELATIVE EFFECTIVENESS OF INFLUENZA VACCINES". This contract, which has a term ending on March 17, 2025, is not set aside. Marshfield Clinic, Inc., a non-profit healthcare organization, will be providing services related to evaluating the effectiveness of influenza vaccines. This contract is part of a larger Vaccine Safety...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization, for a project titled "USING ELECTRONIC HEALTH RECORDS TO IDENTIFY AND DESCRIBE". The contract has a ceiling value of $1,029,344.00 and a period of performance ending on September 27, 2027. It is a firm fixed price contract and was not set aside for any particular business type. Marshfield Clinic, Inc. is a subsidiary of...
This federal contract award is for a project under the Vaccine Safety Datalink (VSD) between the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) and Marshfield Clinic, Inc., a non-profit healthcare organization. The $2,925,737.80 delivery order contract is for the provision of critical functions related to the VSD project, which supports vaccine safety monitoring and research. As the prime contractor, Marshfield Clinic will provide ongoing vaccine...